Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparin
- 1 February 1999
- journal article
- research article
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 21 (1) , 55-60
- https://doi.org/10.1046/j.1365-2257.1999.00183.x
Abstract
In this study we compare three chromogenic methods (IL‐Heparin, Stachrom Heparin and Heparin Sigma) on two different instruments (ACL300+ and AMAX CS190) for patients on dalteparin (n = 41), a low mo...Keywords
This publication has 10 references indexed in Scilit:
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- The Therapeutic Range for Heparin Therapy: Relationship between Six Activated Partial Thromboplastin Time Reagents and Two Heparin AssaysThrombosis and Haemostasis, 1996
- Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor XThe Journal of Thoracic and Cardiovascular Surgery, 1996
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Deep-Vein ThrombosisNew England Journal of Medicine, 1994
- The International Normalized RatioArchives of internal medicine (1960), 1994
- The international normalized ratio. A guide to understanding and correcting its problemsArchives of internal medicine (1960), 1994
- Low Molecular Weight Heparin Therapy: Is Monitoring Needed?Thrombosis and Haemostasis, 1994
- Establishing a Therapeutic Range for Heparin TherapyAnnals of Internal Medicine, 1993
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986